Recombinant human erythropoietin: Effect on the functional performance of anemic orthopedic patients

Lawler, Mary H.; Rosen, Michelle H.; Bloom, Stephen; Duerden, Marc E.; Turba, Rose M.; Kern, H.; Kirschner, Kristi L.; Ronin, David

doi:10.1016/s0003-9993(96)90105-7

Cited by 13 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, the application of recombinant human (rHu) EPO in transfusion‐dependent surgery shows that regimens with rHu EPO given subcutaneously during the perioperative period are effective in increasing Hb levels and reducing the need for homologous blood transfusions (Levine et al , 1989a,b; Kyo et al , 1992; Canadian orthopedic perioperative erythropoietin study group, 1993; Green et al , 1996; Faris et al , 1996). A dose of 600 IU/kg in patients with multiple organ failure induces a rise in reticulocyte count despite high levels of cytokines (Gabriel et al , 1998).…”

Section: Other Mechanismsmentioning

confidence: 99%

Acute event‐related anaemia

Iperen¹,

Wiel

Marx³

2001

Br J Haematol

View full text Add to dashboard Cite

Section: Other Mechanismsmentioning

confidence: 99%

Acute event‐related anaemia

Iperen¹,

Wiel

Marx³

2001

Br J Haematol

View full text Add to dashboard Cite

Prevalence and outcomes of anemia in surgery: a systematic review of the literature

Shander

Knight²,

Thurer

et al. 2004

The American Journal of Medicine

340

232

View full text Add to dashboard Cite

Untreated preoperative anemia and acute perioperative blood loss may add to surgical risk. To understand the prevalence of anemia in surgical patients (with a primary focus on preoperative anemia), and the impact that preexisting anemia has on transfusion rates as well as on clinical and functional outcomes, a systematic review was performed of articles published between January 1966 and February 2003. The estimates of anemia prevalence in the literature ranged widely, from 5% in geriatric women with hip fracture to 75.8% in patients with Dukes stage D colon cancer. Diagnosis of anemia was most strongly associated with an increased risk of receiving an allogeneic transfusion. In general, patients who donated autologous blood preoperatively received less allogeneic blood than those who did not donate. There was some suggestion that lower hemoglobin levels are associated with decreased survival rates, although this was not found universally. Too few studies were found that evaluated the impact of anemia on other outcomes, such as functional status and costs and resource utilization, to draw reliable conclusions. Several other factors also limited the interpretation of the data, including the lack of a uniform definition for anemia and a dearth of studies expressly designed to quantify the prevalence and impact of anemia. Establishing a uniform definition and specifically evaluating the effect of anemia on outcomes are important considerations for future study.

show abstract